Literature DB >> 33217512

Infection control response to an outbreak of OXA-23 carbapenemase-producing carbapenem-resistant Acinetobacter baumannii in a skilled nursing facility in Utah.

Amanda R Smith1, Maureen Vowles1, Roberta Z Horth2, Lori Smith1, Linda Rider1, Jennifer M Wagner1, Anna Sangster1, Erin L Young1, Hailey Schuckel1, James Stewart1, Randon J Gruninger1, Alessandro Rossi1, Kelly F Oakeson1, Allyn K Nakashima1.   

Abstract

BACKGROUND: Antibiotic-resistant Acinetobacter species are a growing public health threat, yet are not nationally notifiable, and most states do not mandate reporting. Additionally, there are no standardized methods to detect Acinetobacter species colonization.
METHODS: An outbreak of carbapenem-resistant Acinetobacter baumannii (CRAB) was identified at a Utah ventilator unit in a skilled nursing facility. An investigation was conducted to identify transmission modes in order to control spread of CRAB. Culture-based methods were used to identify patient colonization and environmental contamination in the facility.
RESULTS: Of the 47 patients screened, OXA-23-producing CRAB were detected in 10 patients (21%), with 7 patients (15%) having been transferred from out-of-state facilities. Of patients who screened positive, 60% did not exhibit any signs or symptoms of active infection by chart review. A total of 38 environmental samples were collected and CRAB was recovered from 37% of those samples. Whole genome sequencing analyses of patient and environmental isolates suggested repeated CRAB introduction into the facility and highlighted the role of shared equipment in transmission.
CONCLUSIONS: The investigation demonstrated this ventilated skilled nursing facility was an important reservoir for CRAB in the community and highlights the need for improved surveillance, strengthened infection control and inter-facility communication within and across states.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Acinetobacter; Carbapenem-resistant; Infection control; Outbreak; Skilled nursing facility

Mesh:

Substances:

Year:  2020        PMID: 33217512      PMCID: PMC8803644          DOI: 10.1016/j.ajic.2020.11.012

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  32 in total

Review 1.  The epidemiology and control of Acinetobacter baumannii in health care facilities.

Authors:  Pierre Edouard Fournier; Hervé Richet
Journal:  Clin Infect Dis       Date:  2006-01-26       Impact factor: 9.079

2.  Prevalence and antimicrobial patterns of Acinetobacter baumannii on hands and nares of hospital personnel and patients: the iceberg phenomenon again.

Authors:  Sharon Bayuga; Cosmina Zeana; Jyoti Sahni; Phyllis Della-Latta; Wafaa el-Sadr; Elaine Larson
Journal:  Heart Lung       Date:  2002 Sep-Oct       Impact factor: 2.210

3.  Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.

Authors:  Kyle B Enfield; Nujhat N Huq; Megan F Gosseling; Darla J Low; Kevin C Hazen; Denise M Toney; Gavin Slitt; Heidi J Zapata; Heather L Cox; Jessica D Lewis; John R Kundzins; Amy J Mathers; Costi D Sifri
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05-15       Impact factor: 3.254

4.  Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States.

Authors:  Jennifer M Adams-Haduch; Ezenwa O Onuoha; Tatiana Bogdanovich; Guo-Bao Tian; Jonas Marschall; Carl M Urban; Brad J Spellberg; Diane Rhee; Diane C Halstead; Anthony W Pasculle; Yohei Doi
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

5.  Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission.

Authors:  Natalia Blanco; Anthony D Harris; Clare Rock; J Kristie Johnson; Lisa Pineles; Robert A Bonomo; Arjun Srinivasan; Melinda M Pettigrew; Kerri A Thom
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

6.  Screening for Acinetobacter baumannii colonization by use of sponges.

Authors:  Yohei Doi; Ezenwa O Onuoha; Jennifer M Adams-Haduch; Diana L Pakstis; Traci L McGaha; Carly A Werner; Bridget N Parker; Maria M Brooks; Kathleen A Shutt; Anthony W Pasculle; Carlene A Muto; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

7.  Evaluation of carriage and environmental contamination by carbapenem-resistant Acinetobacter baumannii.

Authors:  A Nutman; A Lerner; D Schwartz; Y Carmeli
Journal:  Clin Microbiol Infect       Date:  2016-09-03       Impact factor: 8.067

Review 8.  How long do nosocomial pathogens persist on inanimate surfaces? A systematic review.

Authors:  Axel Kramer; Ingeborg Schwebke; Günter Kampf
Journal:  BMC Infect Dis       Date:  2006-08-16       Impact factor: 3.090

9.  Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.

Authors:  Shinhye Cheon; Mi-Ja Kim; Seon-Jin Yun; Jae Young Moon; Yeon-Sook Kim
Journal:  Korean J Intern Med       Date:  2016-02-15       Impact factor: 2.884

10.  An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital.

Authors:  Eli Ben-Chetrit; Yonit Wiener-Well; Emil Lesho; Puah Kopuit; Chaya Broyer; Liora Bier; Marc V Assous; Shmuel Benenson; Matan J Cohen; Patrick T McGann; Erik Snesrud; Phillip D Levin
Journal:  Crit Care       Date:  2018-11-21       Impact factor: 9.097

View more
  2 in total

1.  Quantifying and interpreting inequality of surgical site infections among operating rooms.

Authors:  Franklin Dexter; Richard H Epstein; Randy W Loftus
Journal:  Can J Anaesth       Date:  2021-02-05       Impact factor: 5.063

Review 2.  Pathogenesis of Gram-Negative Bacteremia.

Authors:  Caitlyn L Holmes; Mark T Anderson; Harry L T Mobley; Michael A Bachman
Journal:  Clin Microbiol Rev       Date:  2021-03-10       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.